Drug Delivery for Movement Disorders.

Prog Neurol Surg

Published: August 2018

There has been substantial research interest in delivering therapeutic neurotrophic factors directly to the brain for the treatment of Parkinson's Disease (PD) and other movement disorders. Direct infusion of glial cell-line derived neurotrophic factor has been investigated in both pre-clinical models and clinical trials. In this chapter we discuss past and present research investigating the potential of direct drug delivery to the brain for the treatment of PD and other movement disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481108DOI Listing

Publication Analysis

Top Keywords

movement disorders
12
drug delivery
8
brain treatment
8
delivery movement
4
disorders substantial
4
substantial interest
4
interest delivering
4
delivering therapeutic
4
therapeutic neurotrophic
4
neurotrophic factors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!